Kate Walsh1, Monica Uddin2, Richelo Soliven3, Derek E Wildman3, Bekh Bradley4. 1. Columbia University Mailman School of Public Health, New York, NY 10032, United States. Electronic address: klw2153@columbia.edu. 2. Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48201, United States; Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI 48201, United States. 3. Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48201, United States. 4. Atlanta VA Medical Center, Decatur, GA 30033, United States; Emory University School of Medicine, Atlanta, GA 30322, United States.
Abstract
BACKGROUND: Prior studies have found that the 5-HTTLPR polymorphism in the promoter region of the serotonin transporter gene (SLC6A4) interacts with stressful life events to increase general risk for PTSD, but this association has not extended to African American samples. Further, little is known about the effects of this interaction on specific PTSD symptom clusters, despite indications that clusters may have different biological substrates. The current study examined the interaction between exposure to childhood emotional abuse and 5-HTTLPR genotype on risk for PTSD symptom severity and severity of specific PTSD symptom clusters in two African American samples. METHODS: Participants were 136 African American household residents from Detroit, MI and 546 African American patients recruited from waiting rooms in primary care clinics in Atlanta, GA. Participants reported emotional abuse exposure and PTSD symptom severity, and provided DNA for triallelic 5-HTTLPR genotyping. Analysis of covariance (ANCOVA) was used to examine main effects and interactions. RESULTS: In both African American samples, 5-HTTLPR genotype modified the effect of emotional abuse on PTSD symptom severity. Participants with the low-expression SS genotype who were exposed to emotional abuse had significantly lower reexperiencing and arousal symptom severity scores. LIMITATIONS: The DNHS genetic sample size was small, and abuse data were assessed retrospectively. CONCLUSIONS: The SS variant of 5-HTTLPR appears to buffer against developing the reexperiencing and arousal symptoms of PTSD in two independent African American samples exposed to childhood emotional abuse. Findings also highlight the importance of considering emotional abuse experiences in patients with suspected PTSD.
BACKGROUND: Prior studies have found that the 5-HTTLPR polymorphism in the promoter region of the serotonin transporter gene (SLC6A4) interacts with stressful life events to increase general risk for PTSD, but this association has not extended to African American samples. Further, little is known about the effects of this interaction on specific PTSD symptom clusters, despite indications that clusters may have different biological substrates. The current study examined the interaction between exposure to childhood emotional abuse and 5-HTTLPR genotype on risk for PTSD symptom severity and severity of specific PTSD symptom clusters in two African American samples. METHODS:Participants were 136 African American household residents from Detroit, MI and 546 African American patients recruited from waiting rooms in primary care clinics in Atlanta, GA. Participants reported emotional abuse exposure and PTSD symptom severity, and provided DNA for triallelic 5-HTTLPR genotyping. Analysis of covariance (ANCOVA) was used to examine main effects and interactions. RESULTS: In both African American samples, 5-HTTLPR genotype modified the effect of emotional abuse on PTSD symptom severity. Participants with the low-expression SS genotype who were exposed to emotional abuse had significantly lower reexperiencing and arousal symptom severity scores. LIMITATIONS: The DNHS genetic sample size was small, and abuse data were assessed retrospectively. CONCLUSIONS: The SS variant of 5-HTTLPR appears to buffer against developing the reexperiencing and arousal symptoms of PTSD in two independent African American samples exposed to childhood emotional abuse. Findings also highlight the importance of considering emotional abuse experiences in patients with suspected PTSD.
Authors: Monica Uddin; Allison E Aiello; Derek E Wildman; Karestan C Koenen; Graham Pawelec; Regina de Los Santos; Emily Goldmann; Sandro Galea Journal: Proc Natl Acad Sci U S A Date: 2010-05-03 Impact factor: 11.205
Authors: Michele L Pergadia; Anne L Glowinski; Naomi R Wray; Arpana Agrawal; Scott F Saccone; Anu Loukola; Ulla Broms; Tellervo Korhonen; Brenda W J H Penninx; Julia D Grant; Elliot C Nelson; Anjali K Henders; Andrew J Schrage; Yi-Ling Chou; Kaisu Keskitalo-Vuokko; Qin Zhu; Scott D Gordon; Jacqueline M Vink; Eco J C de Geus; Stuart Macgregor; Jimmy Z Liu; Gonneke Willemsen; Sarah E Medland; Dorret I Boomsma; Grant W Montgomery; John P Rice; Alison M Goate; Andrew C Heath; Jaakko Kaprio; Nicholas G Martin; Pamela A F Madden Journal: Am J Psychiatry Date: 2011-05-15 Impact factor: 18.112
Authors: Thomas A Mellman; Tanya Alim; Denver D Brown; Elena Gorodetsky; Beata Buzas; William B Lawson; David Goldman; Dennis S Charney Journal: Depress Anxiety Date: 2009 Impact factor: 6.505
Authors: Hans Jörgen Grabe; Carsten Spitzer; Christian Schwahn; Agnes Marcinek; Antje Frahnow; Sven Barnow; Michael Lucht; Harald Jürgen Freyberger; Ulrich John; Henri Wallaschofski; Henry Völzke; Dieter Rosskopf Journal: Am J Psychiatry Date: 2009-06-01 Impact factor: 18.112
Authors: Nathan A Kimbrel; Sandra B Morissette; Eric C Meyer; Roberta Chrestman; Robert Jamroz; Paul J Silvia; Jean C Beckham; Keith A Young Journal: Anxiety Stress Coping Date: 2014-11-14
Authors: Michael T Nedelcovych; Robert W Gould; Xiaoyan Zhan; Michael Bubser; Xuewen Gong; Michael Grannan; Analisa T Thompson; Magnus Ivarsson; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones Journal: ACS Chem Neurosci Date: 2015-01-28 Impact factor: 4.418
Authors: Kenneth Blum; M C Gondré-Lewis; E J Modestino; L Lott; D Baron; D Siwicki; T McLaughlin; A Howeedy; M H Krengel; M Oscar-Berman; P K Thanos; I Elman; M Hauser; L Fried; A Bowirrat; R D Badgaiyan Journal: Mol Neurobiol Date: 2019-05-23 Impact factor: 5.590
Authors: Allison E Ashley-Koch; Melanie E Garrett; Jason Gibson; Yutao Liu; Michelle F Dennis; Nathan A Kimbrel; Jean C Beckham; Michael A Hauser Journal: J Affect Disord Date: 2015-06-12 Impact factor: 4.839
Authors: Janitza L Montalvo-Ortiz; Joel Gelernter; James Hudziak; Joan Kaufman Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2015-11-22 Impact factor: 3.568
Authors: Thalida E Arpawong; Jinkook Lee; Drystan F Phillips; Eileen M Crimmins; Morgan E Levine; Carol A Prescott Journal: Behav Genet Date: 2015-09-02 Impact factor: 2.805
Authors: Jeffrey S Simons; Raluca M Simons; Carol O'Brien; Scott F Stoltenberg; Jessica A Keith; Jaime A Hudson Journal: Addict Behav Date: 2016-09-04 Impact factor: 3.913